Our Track Record

Our IP Excellence Program has enabled over 16 companies with unique technologies that we co-founded or launched in the early-stages to develop into technology leaders with a combined aggregate market value of $26B+.

From ideas to multi-billion-dollar valuations

Acquired by Sanofi for $2.9B

Acquired by Pfizer for $14B

Idea to $1B+ public market valuation

Idea to $3.5B+ public market valuation

Idea to $1B+ public market valuation

Up Next

News & Media